Skip to main content
Premium Trial:

Request an Annual Quote

Health Reform Covers Breast Cancer Test

Genetic testing for breast cancer is to be covered as a preventive service under the US Affordable Care Act, reports MyHealthNewsDaily. A clarification from the Department of Health and Human Services, the Department of Labor, and the Department of Treasury says that asymptomatic, high-risk women — typically with a family history of breast or ovarian cancer — will be able to get tested for the breast cancer risk genes BRCA1 and BRCA2 with no co-pay. This rule applies to non-grandfathered insurance plans.

"We view this clarification as a recognition of the critical value of BRACAnalysis as a preventive service in women's health," Pete Meldrum, the president and CEO of Myriad, says in a statement. "This designation goes a long way in ensuring that high-risk women can now have access to the life-saving preventive information provided by BRACAnalysis without the financial burden of out-of-pocket expenses."

As our sister publication Pharmacogenomics Reporter notes, Myriad is the only commercial US provider of BRCA testing and "this classification will likely broaden access to Myriad's BRCA tests."

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.